A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the systemic and ocular safety and tolerability,
pharmacokinetics, exploratory efficacy and pharmacodynamics of 3 months of repeat
administration of oral darapladib in diabetic macular edema patients with centre involvement.